Impairments weigh on AfroCentric annual results
Profit after tax was down 74.9% in the company’s latest financial year, while HEPS went up 11%
03 September 2024 - 20:08
Investment holding company AfroCentric reported mixed annual results for the year to end-June. While impairments dragged down the group’s profit for the period, higher headline earnings are an indication the SA pharmaceutical sector is returning to prepandemic levels.
AfroCentric, whose controlling shareholding was acquired by Sanlam in 2023, owns and operates a range of healthcare-related enterprises, servicing both the private and public sectors. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.